Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations (Q37802965)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 2010
edit
Language Label Description Also known as
English
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations
scientific article published on August 2010

    Statements

    Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluations (English)
    Stefan Vegter
    Mark H Rozenbaum
    Roelien Postema
    Keith Tolley
    1 August 2010
    1651-1661

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit